Fri, 21 Nov 2008 10:52p.m.
Prostate cancer shares some surprising statistics with breast cancer.
According to the latest figures collated, the incidence and mortality rates are almost identical.
In 2005 just over 2,400 women were diagnosed with breast cancer and just over 600 women died.
In the same year more than 2,400 men were diagnosed with prostate cancer and just under 600 died.
However, unlike breast cancer, there is no national Read the rest of this entry »
(NaturalNews) According to the American Cancer Society, close to 190,000 new cases of prostate cancer are diagnosed in the United States yearly. Approximately one man in six will be found to have the disease during his life and about one out of 35 will die from prostate cancer. In fact, prostate cancer is one of the leading causes of cancer death in American men, second only to lung cancer. But evidence is mounting there’s a way men can take action Read the rest of this entry »
The news could be a significant breakthrough in the treatment of the disease, which kills 10,000 UK men every year.
Men already diagnosed with the cancer who were given a daily dose of aspirin or another anti-inflammatory, such as ibuprofen, had r
educed levels of prostate specific antigens (PSA), a protein used as an indication of the severity of the disease.
But scientists are still not sure whether the findings actually mean an improvement Read the rest of this entry »
, even if they have a family history of the disease, a new study finds.
Writing in the December issue of Cancer Epidemiology, Biomarkers & Prevention, researchers said the findings might help doctors better reach those men most in need of the screening.
Prostate cancer is a leading cause of cancer deaths among men, and those who have had a close relative with the disease are more than twice as likely to get it. But if it is caught early enough, Read the rest of this entry »
Researchers have found that some foods may increase and others may decrease the risks of developing prostate cancer.
September is Prostate Cancer Awareness Month and is part of a national effort to help educate men about the disease. Researchers are using the month this year to show and test findings of correlations between diets and diagnoses of prostate cancer.
“They are definitely seeing a relationship between obesity and prostate cancer,” Read the rest of this entry »
ScienceDaily (Sep. 8, 2008)
— Common painkillers like aspirin and ibuprofen appear to lower a man’s PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.
But the authors of the new study caution that men shouldn’t take the painkillers in an effort to prevent prostate cancer just yet.
“We showed that men who regularly took certain medications like aspirin and other non-steroidal Read the rest of this entry »
A study of 1,900 men published in this month’s Journal of Men’s Health shows that careful follow up after prostate cancer is critical for those who are younger or African-American.
As part of this trial, researchers were looking at prostate cancer and its connection to the Gleason Score and any connection with ethnicity and the score.
On a scale of one to ten, the Gleason score measures the aggressiveness of the cancer and the risk of return. Read the rest of this entry »
One large, randomized clinical trial led by
Dr. J. Michael Graziano
found that middle-aged men who took vitamin E or vitamin C for about eight years did not have a lower risk of developing prostate cancer or other kinds of cancer compared to similar men who took placebos.
University of Texas M.D. Anderson Cancer Center
studying the effect of selenium and vitamin E on cancer risk was halted early when neither supplement showed any benefits Read the rest of this entry »
Post-Bulletin, Austin MN
A $1 million federal grant is going to the Hormel Institute to study an herbal compound’s ability to help prevent prostate cancer.
The National Institutes of Health also is providing another $525,000 for supporting the costs related to the project, according to the Hormel Institute.
Junxuan “Johnny” Lu, a cancer biology professor at the Hormel Institute in Austin, will lead the five-year project to study an herbal Read the rest of this entry »
December 30, 2008 11:17 p.m. EST
Washington, DC (AHN) – The U.S. Food and Drug Administration (FDA) has approved a new drug that treats advanced prostate cancer offering an additional option for treating the disease mostly afflicting men.
The federal agency said Monday the injectable degarelix of Parsippany, New Jersey-based Ferring Pharmaceuticals Inc. slows the growth and progression of prostate cancer by suppressing testosterone hormones. Read the rest of this entry »